TEVA GLOBAL OPIOID SETTLEMENT AGREEMENT TEVA GLOBAL OPIOID SETTLEMENT AGREEMENTOpioid Settlement Agreement • March 30th, 2023
Whereas, the Settling States, Participating Subdivisions, Participating Special Districts, and Teva (as those terms are defined below) share a common desire to resolve disputes between them relating to opioid medications according to the terms set out in this agreement dated as of November 22, 2022 (the “Agreement”);
ALLERGAN PUBLIC GLOBAL OPIOID SETTLEMENT AGREEMENTOpioid Settlement Agreement • February 8th, 2023
Whereas, the Settling States, Participating Subdivisions, Participating Special Districts, and Allergan (as those terms are defined below) share a common desire to resolve disputes between them relating to opioid medications according to the terms set out in this agreement dated as of November 22, 2022 (the “Agreement”);
ALLERGAN PUBLIC GLOBAL OPIOID SETTLEMENT AGREEMENT ALLERGAN PUBLIC GLOBAL OPIOID SETTLEMENT AGREEMENTOpioid Settlement Agreement • July 24th, 2023
Whereas, the Settling States, Participating Subdivisions, Participating Special Districts, and Allergan (as those terms are defined below) share a common desire to resolve disputes between them relating to opioid medications according to the terms set out in this agreement dated as of November 22, 2022 (the “Agreement”);
ALLERGAN NEW YORK STATEWIDE OPIOID SETTLEMENT AGREEMENTOpioid Settlement Agreement • December 8th, 2021 • New York
TEVA/NEW YORK STATEWIDE OPIOID SETTLEMENT AGREEMENTOpioid Settlement Agreement • November 3rd, 2022 • New York
TEVA GLOBAL OPIOID SETTLEMENT AGREEMENT TEVA GLOBAL OPIOID SETTLEMENT AGREEMENTOpioid Settlement Agreement • October 22nd, 2023
Whereas, the Settling States, Participating Subdivisions, Participating Special Districts, and Teva (as those terms are defined below) share a common desire to resolve disputes between them relating to opioid medications according to the terms set out in this agreement dated as of November 22 Ag ree mWenKt´H ³
ALLERGAN PUBLIC GLOBAL OPIOID SETTLEMENT AGREEMENTOpioid Settlement Agreement • February 8th, 2023
Whereas, the Settling States, Participating Subdivisions, Participating Special Districts, and Allergan (as those terms are defined below) share a common desire to resolve disputes between them relating to opioid medications according to the terms set out in this agreement dated as of November 22, 2022 (the “Agreement”);
JANSSEN WASHINGTON STATE-WIDE OPIOID SETTLEMENT AGREEMENTOpioid Settlement Agreement • January 22nd, 2024
This settlement agreement (the “Agreement”) sets forth the terms and conditions of a settlement agreement between and among Janssen, the State of Washington, and Participating Subdivisions (as those terms are defined below). Janssen has agreed to the below terms for the sole purpose of settlement, and nothing herein may be taken as or construed to be an admission or concession of any violation of law, rule, or regulation, or of any other matter of fact or law, or of any liability or wrongdoing, all of which Janssen expressly denies. No part of this Agreement, including its statements and commitments, shall constitute evidence of any liability, fault, or wrongdoing by Janssen. Unless the contrary is expressly stated, this Agreement is not intended for use by any third party for any purpose, including submission to any court for any purpose.
TEVA/NEW YORK STATEWIDE OPIOID SETTLEMENT AGREEMENTOpioid Settlement Agreement • November 10th, 2022 • New York
ALLERGAN PUBLIC GLOBAL OPIOID SETTLEMENT AGREEMENTOpioid Settlement Agreement • November 22nd, 2022
Whereas, the Settling States, Participating Subdivisions, Participating Special Districts, and Allergan (as those terms are defined below) share a common desire to resolve disputes between them relating to opioid medications according to the terms set out in this agreement dated as of November 22, 2022 (the “Agreement”);
TEVA GLOBAL OPIOID SETTLEMENT AGREEMENTOpioid Settlement Agreement • August 2nd, 2023 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • Oklahoma
Whereas, the Settling States, Participating Subdivisions, Participating Special Districts, and Teva (as those terms are defined below) share a common desire to resolve disputes between them relating to opioid medications according to the terms set out in this agreement dated as of November 22, 2022 (the “Agreement”);
